LanzaTech will license TeselaGen’s proprietary cloud-based informatics solution and will collaborate closely with TeselaGen, extending its state-of-the-art biological design platform to include artificial intelligence capabilities that speed up the design process.
Arzeda and TeselaGen announced that Arzeda will license TeselaGen’s proprietary cloud-based informatics solution and collaborate to extend TeselaGen’s state-of-the-art biological design automation platform.
Innovative use of molecular design technology is essential for discovering and developing new agricultural products at a faster pace. Today, TeselaGen Biotechnology Inc., and Dow AgroSciences, LLC (NYSE: DOW), announced they have entered a new phase in their collaboration to produce a state-of-the-art biological design automation platform that can speed discovery work.
JBEI was selected as one of four DOE Bioenergy Research Centers (BRCs) to receive funding in support of innovative research on biofuels and bioproducts. JBEI receives additional support from the California Energy Commission, TeselaGen Biotechnology Inc., and the Heising-Simons Foundation.
TeselaGen has received a $500,000 matching grant to further develop its enterprise software platform for gene editing and engineering.
The In-Fusion Cloning Primer Design Tool, powered by TeselaGen, generates primer sequences and vector maps.